Immune gene expression and response to chemotherapy in advanced breast cancer | British Journal of Cancer
Loop | Ioannis Zerdes
SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12. - Abstract - Europe PMC
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
![PDF] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b35807a7b2a40d1d66ecfaf04ea6916752e28c9b/38-Table5-1.png "PDF] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy | Semantic Scholar")
PDF] Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy | Semantic Scholar
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations | Oncogene
Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Ioannis Zerdes (ioanniszerdes) - Profile | Pinterest
Ioannis Zerdes (ioanniszerdes) - Profile | Pinterest
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - ScienceDirect
SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12 | Cell Death & Disease
Ioannis Zerdes - Postdoctoral Researcher - Karolinska Institutet | LinkedIn
Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Zerdes Ioannis Katsiapis Nikolaos in Pireas, Greece Information and Review
PD-1 protein and gene expression as prognostic factors in early breast cancer - ESMO Open
Ioannis Zerdes (ioanniszerdes) - Profile | Pinterest
Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis - Cancer Treatment Reviews
同样是meta分析整合生信分析，为何这篇能发12+？ 原创- 知乎
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Pertuzumab, Trastuzumab, and Docetaxel for Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia - Researcher | An App For Academics
Uterine Cervical Cancer | SpringerLink
Immune gene expression and response to chemotherapy in advanced breast cancer | British Journal of Cancer
Ioannis Zerdes (ioanniszerdes) - Profile | Pinterest
Jonas Bergh's Group | Karolinska Institutet
Ioannis Zerdes - Postdoctoral Researcher - Karolinska Institutet | LinkedIn
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
